BIRC5 and chronic myelogenous leukemia, BCR-ABL1 positive: A study by Jung et al. showed that 1-stearoyl-sn-glycero-3-phosphocholine (LPC), one of the lysophosphatidylcholines, decreased HDAC3 expression and suppressed the binding of HDAC3 to the promotor of survivin in chronic myelogenous leukemia K562 cells in vitro (Jung et al., 2013).